Clinical trial

Glaucoma Biomarkers

NCT01677507

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-08-01

PhasePHASE4

Study timeline

Study start (unknown)2012-08-01Date precision: month

Registry last updated2017-09-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucomaverified · MONDO: glaucoma

Healthyunresolved

Interventions

Variation in eye pressure response to timolol and latanoprost treatmentDRUG

Sponsors & collaborators

University of Michiganlead sponsor

University of Nebraskacollaborator

Mayo Cliniccollaborator

National Eye Institute (NEI)collaborator

Mapped research locations

OmahaNebraska, United States1 Ann ArborMichigan, United States1 RochesterMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01677507 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.